Globe & Mail on TryCycle and IBM Partnership

September 20, 2018

Today's Globe & Mail contains a story detailing IBM's efforts to attack the opioid crisis with Artificial Intelligence and Machine Learning. Included in the story is a discussion about the partnership between TryCycle and IBM in this important effort.

From the feature:

MacBeth thinks this is a small price to pay for unchaining the counsellor response “from the tyranny of a calendar.”

He adds that “it makes absolutely no sense that a person who is in a crisis situation now has to wait two or three weeks to get an appointment with a practitioner. With something like TryCycle, response times can change and this reduces the strain on already stressed emergency and health resources; more importantly, it can help save lives.

Visit the Globe & Mail website to read the story

Local Spotlight: Substance Abuse Programs Adopt Mobile Tool

August 1, 2018

TryCycle CEO, John MacBeth, speaks with Robert Hayek at Addiction Now, about supply and demand issues, technology, and hope, amidst the opioid epidemic.  “The system is designed specifically to help practitioners become significantly more efficient in how they manage caseloads,” MacBeth said. “The more we learn, the earlier we can predict behavior, the easier it is for a practitioner to get away from his calendar and see a patient.”

Read the full story here.

TryCycle Joins UCONN TIP; largest university-based technology business incubation program in Connecticut

June 25, 2018

400 Farmington Ave.

J. Gelineau/UConn Photo

A comprehensive platform, the Technology Incubation Program (TIP) provides a unique ecosystem to support innovators and entrepreneurs to succeed through the most critical stages of their journey. “We’re very proud to be accepted into the UConn TIP community,” TryCycle President and CEO John MacBeth said. “The opportunity to access leading edge experience and resources will help accelerate our path to commercialization.”

Click here to read the full story or download a pdf.

TryCycle Featured in The Hartford Courant

July 24, 2018

"To Fight Opioid Epidemic, Farmington Startup Creates 'Digital Tether' Between Patient And Doctor"

The Hartford Courant caught up with TryCycle Data Systems founders, John MacBeth and Ken House, and featured the advances that the platform is bringing to opioid treatment in Connecticut.

The crisis is only gaining speed in Connecticut. In the last five years, the state has reported 4,083 accidental drug-related deaths, including more than 1,000 deaths in 2017 alone, according to data from the Office of the Chief Medical Examiner. But new tools like TryCycle are helping to stem the tide of relapse and repeat overdose.

According to Dr. Jim O'Dea, vice president of operations at Hartford Healthcare Behavioral Health Network:

It's an innovation in care delivery.

TryCycle is featured on IBM’s home page!

June 12, 2018

Find out how we’re using Watson AI to fight opioid addiction and treat people in recovery.

IBM Recognizes Success at TryCycle

May 29, 2018

IBM LogoIBM has recognized the important work that TryCycle Data Systems is doing to support opioid recovery, and has featured CEO and Founder, John MacBeth, on their Client Success Field Notes website.

The TryCycle platform utilizes multiple services from the IBM Watson catalogue, including sentiment analysis, tone analyzer, and Watson Studio to better interpret the data that our clients generate.

Learn more about the story behind TryCycle Data Systems, how we engage with the IBM platform, and where we want to go next with our unique technology.

TryCycle Data Visits the Capital Angel Network

Ottawa, December 13, 2017

John MacBeth,TryCycle Data Founder and CEO, was featured at the final Capital Angel Network “Mashup & Social” event for 2017 at the Canadian Museum of History.

Below is the five-minute interview with John on the future of TryCycle - compliments of Techopia Live.

After 125 years of status quo, it’s time to Try a new care Cycle in the fight against substance use.John MacBeth

Jonathan Rezek on AI Accelerating Medical Breakthroughs

Ottawa, December 12, 2017

Jonathan Rezek is a member of the National Innovation Team at IBM Canada and a great friend to everyone at TryCycle Data.

Please watch this remarkably personal video about Jonathan and his vision to harness the power of IBM Watson in the field of Parkinson’s medical research.

TryCycle CEO on 1310 News

1310 Logo

Ottawa, December 7, 2017

TryCycle Data Founder and CEO, John MacBeth, was featured in an interview on AM 1310 News today. The broad ranging conversation focused on the growing opioid crisis and the approach that TryCycle Data is taking to help medical professionals tackle the behavioral issues.

Listen to the full 10 minute interview in the player below.

Ottawa, November 20, 2017

TryCycle Data continues to grow and gain recognition in the community, and today we are proud to announce that TryCycle Data is the featured cover story for this week's edition of the Ottawa Business Journal!

The story is titled, 'Early warning system' gives opioid addicts new weapon in fight to stay clean, and features an interview with CEO, John MacBeth.

It’s an early warning system for reusing. It sounds simple, but it’s taken a few years to crack the code.John MacBeth, CEO

Ottawa, November 8, 2017

CNA LogoJohn MacBeth, CEO & President of TryCycle Data and Mike Villeneuve, CEO of the Canadian Nurses Association (CNA) delivered a joint announcement today about their new partnership agreement.

Said Villeneuve,Health-system funders and decision-makers constantly face challenges when deciding which technologies will better serve patients and health-care providers. In partnering with TryCycle, CNA will bring nurses — health professionals with critical insights into what works best for delivering care — to the table to inform discussions and help guide and test e-tools to improve access, effectiveness, timeliness and appropriateness of care. This affiliation creates a mechanism to develop and validate innovative tools and resources that are badly needed now."

Learn more about this exciting partnership.